-
Medical journals
- Career
Monitoring of surface cytotoxic drugs in the environment of hospital pharmacies in the Czech Republic
Authors: P. Odráška 1,2; L. Gorná 1; L. Doležalová 1; M. Oravec 2; J. Kuta 2; L. Bláha 1,2
Authors‘ workplace: Masarykův onkologický ústav Brno 1; Masarykova univerzita Brno, Přírodovědecká fakulta, RECETOX (Výzkumné centrum pro chemii životního prostředí a ekotoxikologii) 2
Published in: Čes. slov. Farm., 2009; 58, 225-229
Category: Original Articles
Overview
The study aimed to determine the contamination with antineoplastic (cytotoxic) drugs in 15 hospital pharmacies in the Czech Republic and to investigate the relationship between the level of contamination and the work load (number of preparations per week reported by the given pharmacy staff). For this purpose, surface contamination of the most exposed locations within the preparation and storage areas was monitored. Monitored surfaces were wiped with a nonwoven swab moistened with acetate buffer (0.02 M, pH = 4). Wipers were then extracted in the same solution and analysed for cyclophosphamide and platinum contents by high-performance liquid chromatography with mass spectrometry (HPLC-MS) and inductively coupled plasma mass spectrometry (ICP-MS), respectively. From the total of 119 collected samples, 70 samples (59%) were positive for at least one of the analytes and 43 samples (36%) were positive for both compounds studied. In general, the levels of contamination were higher in the preparation rooms than in the storage areas. Furthermore, it was shown that contamination is more frequent in those pharmacies where high numbers of preparations are routinely processed. Nevertheless, individual levels of contamination seem to be influenced also by the staff dedication and spatial organization of working areas.
Key words:
antineoplastic agents – contamination – cyclophosphamide – platinum – pharmacy
Sources
1. Hedmer, M., Tinnerberg, H., Axmon, A., Jonsson, B. A. G.: Int. Arch. Occup. Environ. Health, 2008; 81, 899–911.
2. Heinemann, A., Hadtstein, C.: ASUpraxis, 2009; 44, 37–39.
3. Wieringa, A., van Staveren, M. C., van der Aart-van der Beek, A., Visser, T.: Europ. J. Hosp. Pharm., 2008; 14, 94–95.
4. Kromhout, H., Hoek, F., Uitterhoeve, R., Huijbers, R., Overmars, R. F., Anzion, R., Vermeulen, R.: Ann Occup Hyg, 2000; 44, 551–560.
5. McDevitt, J. J., Lees, P. S. J., McDiarmid, M. A.: J. Occup. Environ. Med., 1993; 35, 57–60.
6. Sessink, P. J. M., Timmersmans, J. L., Anzion, R. B. M., Bos, R. P.: J. Occup. Environ. Med., 1994; 36, 79–83.
7. Sessink, P. J. M., Vandekerkhof, M. C. A., Anzion, R. B. M., Noordhoek, J., Bos, R. P.: Arch. Environ. Health, 1994; 49, 165–169.
8. DiFrancesco, R., Griggs, J. J., Donnelly, J., Di Cenzo, R.: J. Chromatogr. B, 2007; 852, 545–553.
9. Hedmer, M., Jonsson, B. A. G., Nygren, O.: J. Environ. Mon., 2004; 6, 979–984.
10. Minoia, C., Turci, R., Sottani, C., Schiavi, A., Perbellini, L., Angeleri, S., Draicchio, F., Apostoli, P.: Rapid Commun. Mass Spectrom., 1998; 12, 1485–1493.
11. Schmaus, G., Schierl, R., Funck, S.: Am. J. Health. Syst. Pharm., 2002; 59, 956–961.
12. Sessink, P. J. M., Scholtes, M. M., Anzion, R. B. M., Bos, R. P.: J. Chromatogr. Biomed. Appl., 1993; 616, 333–337.
13. Nygren, O., Gustavsson, B., Strom, L., Eriksson, R., Jarneborn, L., Friberg, A.: J. Environ. Mon., 2002; 4, 739–742.
14. Turci, R., Sottani, C., Ronchi, A., Minoia, C.: Toxicol. Lett., 2002; 134, 57–64.
15. Connor, T. H., Anderson, R. W., Sessink, P. J. M., Broadfield, L., Power, L. A.: Am. J. Health. Syst. Pharm., 1999; 56, 1427–1432.
16. Hedmer, M., Georgiadi, A., Bremberg, E. R. M., Jonsson, B. A. G.: Ann. Occup. Hyg., 2005; 49, 629–637.
17. Vandenbroucke, J., Robays, H.: J. Oncol. Pharm. Pract., 2001; 6, 146–152.
18. Sessink, P. J. M., Kroese, E. D., Vankranen, H. J., Bos, R. P.: Int. Arch. Occup. Environ. Health, 1995; 67, 317–323.
19. Čupr, P., Koptíková, J., Šantroch, J., Bartoš, T., Bednářová, Z., Mužík, J., Holoubek, I., Dušek, L.: Klin. onkol., 2007; 20, 190–196.
20. Hirst, M., Mills, D., Tse, S., Levin, L., White, D.: The Lancet, 1984; 323, 186–188.
21. Sessink, P. J. M., Boer, K. A., Scheefhals, A. P. H., Anzion, R. B. M., Bos, R. P.: Int. Arch. Occup. Environ. Health, 1992; 64, 105–112.
Labels
Pharmacy Clinical pharmacology
Article was published inCzech and Slovak Pharmacy
2009 Issue 5-6-
All articles in this issue
- Methods of preparation of microparticles in pharmaceutical technology
- Hypolipidemic effect of amaranth constituents
- Influence of formulation technology on theophylline release from chitosan-based pellets
- Monitoring of surface cytotoxic drugs in the environment of hospital pharmacies in the Czech Republic
- Contributions to the development of advertising in pharmacy I
- A contribution to the histories of the pharmacies of the Brethren of Mercy in the territory of contemporary Slovakia in the first decades of the 20th century
- Examination of selected quality parameters of the parenteral nutrition AIO – a pilot study
- Antimycobacterial activity of novel derivatives of arylcarbonyloxyaminopropanols
- Comparison of renal accumulation of [DOTA0, 1-Nal3]-octreotide labelled with selected radiometals
- Adhesivity of branched plasticized oligoesters
- Czech and Slovak Pharmacy
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue- Methods of preparation of microparticles in pharmaceutical technology
- Contributions to the development of advertising in pharmacy I
- Examination of selected quality parameters of the parenteral nutrition AIO – a pilot study
- Hypolipidemic effect of amaranth constituents
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career